Delcath's Chemosat device scores reimbursement win in Germany

02/5/2013 | American City Business Journals

The German government has approved a reimbursement scheme for Delcath Systems' Chemosat liver chemotherapy device. The decision allows hospitals in the country to negotiate coverage with insurers for procedures that use the system, paving the way for the company to advance its efforts to fully market the technology in Europe.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA